Management of Primary Nonresponders and Partial Responders to Tumor Necrosis Factor-α Inhibitor Induction Therapy among Patients with Crohn’s Disease

Management of Primary Nonresponders and Partial Responders to Tumor Necrosis Factor-α Inhibitor Induction Therapy among Patients with Crohn’s Disease

Induction therapy with tumor necrosis factor-α (TNF-α) inhibitors is highly effective for the treatment of Crohn’s disease. However, there are primary nonresponders (PNR) of TNF-α inhibitors without clinical response during the induction period. In addition, there are partial responders (PR), who sh...

Full description

Bibliographic Details
Main Authors: Hideki Iijima, Taku Kobayashi, Mitsuo Nagasaka, Shinichiro Shinzaki, Kazuya Kitamura, Yasuo Suzuki, Mamoru Watanabe, Toshifumi Hibi
Format: Article
Language:English
Published: Karger Publishers 2020-03-01
Series:Inflammatory Intestinal Diseases
Subjects:
crohn’s disease
infliximab
expert opinion
primary nonresponder
partial responder
Online Access:https://www.karger.com/Article/FullText/506337

Internet

https://www.karger.com/Article/FullText/506337

Similar Items